The Croscarmellose Sodium Market is estimated to be valued at USD 1065.9 million in 2025 and is projected to reach USD 1873.1 million by 2035, registering a compound annual growth rate (CAGR) of 5.8% over the forecast period.
The croscarmellose sodium market has experienced steady expansion in recent years, driven primarily by its rising incorporation across pharmaceutical, food, and personal care industries. Recognized for its superior disintegrating, stabilizing, and binding properties, this multifunctional additive has secured consistent demand in both established and emerging economies.
Market growth has been further bolstered by the escalating preference for excipients that enhance the bioavailability and functionality of formulations without compromising safety or stability. A heightened emphasis on clean-label, food-safe, and non-allergenic ingredients is also contributing to the product's adoption across food and beverage applications.
Over the coming years, favorable regulatory support, coupled with continuous advancements in processing techniques and application-specific grades, is expected to widen its commercial footprint. Sustained demand from nutraceutical and processed food manufacturers, alongside increased consumption of oral solid dosage forms in the pharmaceutical sector, will likely underpin market growth. The market’s resilience is anticipated to remain intact as manufacturers invest in scalable production, diverse sourcing options, and customized grades tailored to evolving industrial requirements.
The market is segmented by Source, Grade, Application, and End Use and region. By Source, the market is divided into Cotton and Wood Pulp. In terms of Grade, the market is classified into Food Grade, Pharmaceutical Grade, and Cosmetic Grade. Based on Application, the market is segmented into Emulsifier, Disintegrant, Dissolution Agent, Stabilizing Agent, Mixing Agent, and Others. By End Use, the market is divided into Food and Beverage Industry, Dietary Supplement Industry, Pharmaceutical Industry, Nutraceutical Industry, Personal Care and Cosmetic Industry, Textile Industry, and Others. Regionally, the market is classified into North America, Latin America, Western Europe, Eastern Europe, Balkan & Baltic Countries, Russia & Belarus, Central Asia, East Asia, South Asia & Pacific, and the Middle East & Africa.
The cotton segment accounted for approximately 57.3% of the total croscarmellose sodium market share, establishing itself as the primary raw material source within the industry. Its dominance has been attributed to consistent supply availability, natural origin, and compatibility with diverse industrial applications.
Manufacturers have increasingly favored cotton-derived croscarmellose sodium due to its reliable purity profile and well-established regulatory acceptance, particularly within pharmaceutical and food-grade formulations. This material source benefits from its renewable nature and lower likelihood of allergenic reactions compared to certain synthetic or alternative cellulose derivatives.
Additionally, the stable cost structure associated with cotton procurement has reinforced its preference among producers seeking to maintain formulation consistency and cost competitiveness. Looking ahead, demand for cotton-based croscarmellose sodium is projected to remain robust, supported by heightened awareness around plant-based excipients and sustained consumption in health, wellness, and processed food sectors.
Within the grade category, the food grade segment led the croscarmellose sodium market with a commanding 49.8% market share. This segment's prominence is largely driven by the expanding global processed food industry, where croscarmellose sodium is extensively employed as a disintegrant, stabilizer, and emulsifying agent.
Food manufacturers increasingly prefer this grade for its ability to improve texture, moisture retention, and shelf-life without altering the sensory profile of products. Its recognized safety status by food regulatory authorities in several countries has further supported its widespread incorporation in sauces, dressings, confectionery, and ready-to-eat items.
The growth trajectory of this segment is also being propelled by consumer demand for convenience foods and clean-label ingredients that deliver both functional and sensory benefits. In the near future, the introduction of enhanced food-grade variants with tailored functionalities is expected to maintain the segment’s leadership position and expand its application breadth in emerging markets.
The emulsifier segment held a significant 35.4% share in the croscarmellose sodium market by application, underpinned by rising demand for stable and effective emulsifying agents across food, pharmaceutical, and personal care industries. Its ability to uniformly disperse immiscible components and improve the texture and stability of final products has positioned it as a preferred choice for formulators.
In the food industry, its application spans sauces, dairy-based items, and baked goods, where consistent texture and extended shelf life are essential. Additionally, pharmaceutical manufacturers leverage its emulsifying properties to enhance the dispersion of active ingredients in oral and topical formulations.
The emulsifier segment’s growth has also been supported by heightened awareness of natural and multifunctional additives that meet stringent regulatory standards. With continuous product innovation and the growing complexity of processed formulations, demand for reliable and versatile emulsifiers like croscarmellose sodium is anticipated to sustain upward momentum across multiple industries.
The croscarmellose sodium market is largely driven by the swift expansion of the pharmaceutical industry. There has been a rapid surge in the prevalence of various diseases and conditions such as hypertension, cardiovascular disease, cancer, hypercholesterolemia, and others over the last few years, resulting in fueling the demand for pharmaceutical products.
Croscarmellose sodium is gaining huge popularity across the pharmaceutical sector, owing to its advantages such as assistance in fast disintegration & dissolution, enhancing flowability, good mixing properties, and increasing stability of the formulation among others.
Attributed to this, it is finding a wide range of applications in the formulation of pharmaceutical products such as therapeutics drugs, capsules, tablets, pellets, and others. Hence, surging demand for pharmaceutical products is projected to bolster the demand for croscarmellose sodium in the global market.
Increasing availability of various others emulsifiers and disintegrants such as crospovidone, sodium starch glycolate, cross-linked alginic acid, and calcium silicate among others are hindering the sales of croscarmellose sodium in the global market.
In addition to this, there are numerous side effects associated with the consumption of croscarmellose sodium such as hepatotoxicity, interstitial nephritis, dyspepsia, fever, pneumonitis, pancreatitis, rashes, pericarditis, and others. Rising awareness regarding these adverse effects is restraining the growth in the market.
As per FMI, South Asia is projected to emerge as a highly remunerative market for croscarmellose sodium during the forecast period 2025-2035.
Due to the increasing stressed lifestyle and changing eating habits, the burden of various disorders and health-related diseases such as obesity, diabetes, hypertension, insomnia, and others is rapidly increasing across South Asia, creating strong demand for therapeutics medications.
For instance, according to the International Diabetes Federation, around 1007.4 Mn people, or nearly 9.6% of the total population in India were reported to be suffering from diabetes in the year 2024. As croscarmellose sodium plays a vital role in the production of pills, tablets, capsules, and other medications, growing burden of such diseases is anticipated to augment the growth in the South Asia market.
North America is expected to exhibit growth at a rapid CAGR in the global croscarmellose sodium market from 2025 to 2035, states Future Market Insights.
With increasing customer inclination toward packaged food & beverages products, there is a swift rise in demand for ready-to-eat snacks, breakfast cereals, bakery products, dairy products, juices, and others. Hence, key industry players are focusing on launching new products to capitalize on the surging demand.
For instance, in 2024, General Mills, Inc., an American multinational manufacturer of consumer foods, announced its plan of launching a new ready-to-eat cereal lineup including CinnaGraham Toast Crunch, Reese’s Puffs Cluster Crunch, and others.
As croscarmellose sodium is used as an emulsifier for the production of aforementioned products, a multiplicity of such new product launches is estimated to favor the growth in the North America market.
Some of the leading players in the croscarmellose sodium market are JRS Pharma LP, NB Entrepreneurs, du Pont de Nemours and Company, Maple Biotech Pvt. Ltd., Roquette Frères, Mingtai Chemical Co., Ltd., FMC Corporation, BASF SE, DFE Pharma, Blanver EN, Ashland Inc., Spectrum Chemical Mfg. Corp., and others.
Attributed to the rising adopting capacity expansion, collaboration, mergers & acquisitions strategies, the market for croscarmellose sodium is highly competitive.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 5% to 6% from 2025 to 2035 |
| Base Year for Estimation | 2024 |
| Historical Data | 2020 to 2024 |
| Forecast Period | 2025 to 2035 |
| Quantitative Units | Revenue in million, Volume in Kilotons and CAGR from 2025 to 2035 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered | Source, Grade, Application, End Use, Region |
| Countries Covered | North America; Latin America; Europe;East Asia; South Asia; Oceania; Middle East and Africa |
| Key Companies Profiled | JRS Pharma LP; NB Entrepreneurs; du Pont de Nemours and Company; Maple Biotech Pvt. Ltd.; Roquette Frères; Mingtai Chemical Co., Ltd.; FMC Corporation; BASF SE; DFE Pharma; Blanver EN; Ashland Inc.; Spectrum Chemical Mfg. Corp.; Others |
| Customization | Available Upon Request |
The global croscarmellose sodium market is estimated to be valued at USD 1,065.9 million in 2025.
It is projected to reach USD 1,873.1 million by 2035.
The market is expected to grow at a 5.8% CAGR between 2025 and 2035.
The key product types are cotton and wood pulp.
food grade segment is expected to dominate with a 49.8% industry share in 2025.
Explore Similar Insights
Croscarmellose Sodium Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
